🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Redx are delighted to be attending the Jefferies London Healthcare Conference and will present today at 15:15 GMT. To watch the presentation live, please click here: bit.ly/3TKeSBm. A recording of the webcast will be available here afterwards: bit.ly/3ULrXvS

Last week, our CEO, Lisa LM Anson joined Donato Mancini at the FT Global Pharma & Biotech Summit to discuss lessons she has learnt since taking the helm in 2018 and successfully guiding 5 drug candidates to the clinic in 4 years. Read more here: bit.ly/3EJf3J2

Redx look forward to attending the Scrip, Citeline Commercial Awards on Wednesday 30th November 2022. We have been shortlisted for Biotech Company of the Year🤞 - for more info, click this link: bit.ly/3DIewXN #biotech #researchanddevelopment #drugdiscovery #drugdevelopment

Redx were delighted to present a poster on RXC008, a GI-targeted ROCK inhibitor which suppresses fibrosis & tissue injury in models of Crohn’s disease last week at the IBD Nordic Conference. Click to view full poster: bit.ly/3Fd6nen #biotech #fibrosis #crohns

Representatives from Redx had a great time at the Scrip Awards yesterday. We were honoured to be nominated for Biotech of the Year as recognition for the substantial progress we have made so far in all aspects of our pipeline #scripawards #biotech #researchanddevelopment

Redx are pleased to announce clinical trial collaboration & supply agreement with MSD, for supply of KEYTRUDA® (pembrolizumab), to be used in combination arm of Redx's ongoing Ph 2 clinical study evaluating RXC004 #biliarycancer Read full RNS here: bit.ly/3FAB8Zn

Redx are pleased to announce the final audited results for year ended 30 Sep 22. To accompany the announcement, management presented significant operational & strategic progress made throughout '22 & milestones expected in '23. Webcast link is here: bit.ly/3YC9Fzi

The team at Redx would like to wish everyone a very happy holiday season! We will certainly be looking to recharge our batteries before commencing 2023 afresh, kicking off with a trip to JP Morgan for our Executive Team!  #drugdevelopment #researchanddevelopment

Redx are looking for a Biology Scientist and Biology Senior Scientist at our fantastic facilities here at Alderley Park. For full details, please click: bit.ly/3awCC8u #researchanddevelopment #biotech #recruitment #drugdevelopment #biologist #biology #drugdiscovery

We're delighted to announce that a team of Redx chemists have been shortlisted for SCI-RSC National Retrosynthesis Comp Congrats to Cinzia Bordoni, Sebastian Lackner & Marie Lepetit. Well done for reaching the final - we wish you the best of luck! Click: bit.ly/402N1kj

Ahead of the UN’s International Day of Women & Girls in Science (bit.ly/3HOadfe) we want to celebrate the 56 women across Redx whose scientific capabilities and skills are at the core of our world-class drug discovery & development expertise #IDWGIS #womeninscience

This week Redx Head of BD, Duncan Young, will be participating in the 16th Annual European Lifesciences Forum as a member of the ‘Pharma Dealmakers Roundtable’ on 2nd March at 07:50 GMT (08:50 CET). Further info can be found here: bit.ly/3E5PmSf #Sachs​_ELSF

Lisa Anson, CEO and Pete Collum, CFO are presenting today at the 43rd Annual Healthcare Conference in Boston, MA. Please click the link to register for the webcast: bit.ly/3SSPQRI #drugdiscovery #researchanddevelopment #biotech

To mark International Women's Day, one of our many talented Chemists Dr Cinzia Bordoni is answering questions on pursuing a career at the “Women in Chem” event at the School of Chemistry #chemistry #drugdiscovery #researchanddevelopment #womeninbiotech #InternationalWomensDay2023

Redx's Chief Medical Officer, Dr Jane Robertson speaks to Proactive's Thomas Warner and highlights RXC004's potential for use as a combination therapy. #researchanddevelopment #oncologyresearch #biotech lnkd.in/eNPpdAmC

We're excited to be attending The Resistant Tumor Microenvironment, Keystone Symposia next week, where Dr. Daniel Wilcock & Dr. Caroline Philips will be presenting additional preclinical efficacy data on lead fibrosis asset, RXC007, and our DDR1/2 discovery programme  #fibrosis

Redx will announce its unaudited interim results to the 31st March 2023 on May 17th. A webcast presentation will be hosted by the Company at 12pm GMT. For further details please see: bit.ly/3VPgVXu #drugdiscovery #researchanddevelopment #interimresults #biotech

Some of our multi-talented team members here at Redx wowed the crowds yesterday with a range of beautifully made tasty bakes to celebrate World Baking Day and also raise a whopping £236 for our chosen charity, Smile Group 😊 Well done team! #worldbakingday #charity

Today, we look forward to meeting with investors and other healthcare leaders at the #JefferiesHealthcare conference where our CEO, Lisa Anson and CFO, Peter Collum will be presenting at 4:30pm ET. Jefferies #drugdiscovery #researchanddevelopment #biotech

In this Powerscourt, a Sodali & Co company podcast, Redx CEO, Lisa Anson speaks to Etain Lavelle about her transition from big pharma to biotech, the current financing challenges facing UK biotech sector & how to scale UK R&D capabilities to be more globally competitive bit.ly/46J00uU